P
CME icon

Pitcairn’s CME Group CME Stock Holding History

Pitcairn’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,778
Closed -$480K – 109
2025
Q3 		$480K Sell
1,778
-572
-24% -$156K 0.04% 355
2025
Q2 		$648K Sell
2,350
-416
-15% -$113K 0.04% 353
2025
Q1 		$734K Buy
2,766
+31
+1% +$7.65K 0.04% 327
2024
Q4 		$635K Sell
2,735
-6
-0.2% -$1.38K 0.04% 358
2024
Q3 		$605K Sell
2,741
-186
-6% -$38.5K 0.04% 378
2024
Q2 		$575K Buy
2,927
+243
+9% +$50.2K 0.04% 398
2024
Q1 		$578K Buy
2,684
+282
+12% +$59.2K 0.04% 395
2023
Q4 		$506K Sell
2,402
-16
-0.7% -$3.41K 0.04% 398
2023
Q3 		$484K Buy
2,418
+61
+3% +$12.1K 0.04% 370
2023
Q2 		$437K Sell
2,357
-213
-8% -$39.4K 0.04% 401
2023
Q1 		$492K Buy
2,570
+57
+2% +$10.3K 0.05% 344
2022
Q4 		$423K Buy
2,513
+86
+4% +$14.9K 0.04% 355
2022
Q3 		$430K Buy
2,427
+32
+1% +$6.32K 0.05% 320
2022
Q2 		$490K Buy
2,395
+21
+0.9% +$4.45K 0.05% 304
2022
Q1 		$565K Buy
2,374
+486
+26% +$114K 0.05% 321
2021
Q4 		$431K Sell
1,888
-29
-2% -$6.38K 0.03% 412
2021
Q3 		$370K Sell
1,917
-47
-2% -$9.52K 0.03% 434
2021
Q2 		$417K Sell
1,964
-15
-0.8% -$3.17K 0.03% 403
2021
Q1 		$404K Buy
1,979
+119
+6% +$23.4K 0.03% 394
2020
Q4 		$338K Sell
1,860
-78
-4% -$13.3K 0.03% 403
2020
Q3 		$324K Sell
1,938
-19
-1% -$3.2K 0.03% 343
2020
Q2 		$318K Sell
1,957
-270
-12% -$48.4K 0.03% 339
2020
Q1 		$385K Buy
2,227
+73
+3% +$14.5K 0.05% 242
2019
Q4 		$432K Sell
2,154
-32
-1% -$6.57K 0.04% 284
2019
Q3 		$462K Sell
2,186
-53
-2% -$11.1K 0.05% 257
2019
Q2 		$435K Buy
2,239
+51
+2% +$9.4K 0.04% 275
2019
Q1 		$360K Buy
2,188
+5
+0.2% +$884 0.04% 292
2018
Q4 		$411K Sell
2,183
-180
-8% -$33.2K 0.05% 224
2018
Q3 		$402K Sell
2,363
-294
-11% -$49.5K 0.04% 309
2018
Q2 		$435K Sell
2,657
-193
-7% -$31.5K 0.05% 280
2018
Q1 		$461K Sell
2,850
-569
-17% -$90.6K 0.05% 260
2017
Q4 		$499K Buy
3,419
+156
+5% +$22.2K 0.05% 264
2017
Q3 		$442K Sell
3,263
-54
-2% -$6.82K 0.05% 276
2017
Q2 		$416K Buy
3,317
+70
+2% +$8.37K 0.05% 272
2017
Q1 		$386K Buy
3,247
+14
+0.4% +$1.68K 0.05% 304
2016
Q4 		$373K Buy
3,233
+538
+20% +$59.9K 0.05% 324
2016
Q3 		$282K Buy
2,695
+73
+3% +$7.62K 0.04% 387
2016
Q2 		$255K Sell
2,622
-15
-0.6% -$1.42K 0.03% 375
2016
Q1 		$253K Buy
2,637
+181
+7% +$16.5K 0.03% 387
2015
Q4 		$223K Buy
2,456
+231
+10% +$21.7K 0.02% 399
2015
Q3 		$207K Sell
2,225
-97
-4% -$9.22K 0.03% 380
2015
Q2 		$216K Sell
2,322
-81
-3% -$7.56K 0.03% 433
2015
Q1 		$227K Buy
2,403
+8
+0.3% +$741 0.03% 439
2014
Q4 		$212K Buy
+2,395
New +$203K 0.02% 442
2014
Q1 		– Sell
-3,379
Closed -$265K – 467
2013
Q4 		$265K Hold
3,379
– – 0.03% 406
2013
Q3 		$250K Sell
3,379
-96
-3% -$7.07K 0.03% 396
2013
Q2 		$264K Buy
+3,475
New +$228K 0.04% 371

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pitcairn's CME Position: Q4 2025 in Review

Pitcairn sold out of CME Group (CME) in Q4 2025, closing a stake of 1,778 shares — an estimated $480K sold.

Pitcairn first reported a position in CME in Q2 2013 and held it in 47 quarters. The position peaked at $734K in Q1 2025. 1,731 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • Pitcairn reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 1,778 CME Group shares in Q4 2025, an estimated $480K.
  • Pitcairn first reported a position in CME Group in Q2 2013 and held it in 47 quarters.
  • Pitcairn's CME Group position peaked at $734K in Q1 2025.
  • 1,731 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.